Latest News

Kansas City Business Journal Recognizes Pharmacy Benefit Manager for Financial Performance, Innovation and Community Involvement

PRESS RELEASE: MedTrakRx, a pharmacy benefit manager (PBM) and a division of EnvisionRxOptions (a wholly owned subsidiary of Rite Aid), was recently selected by the Kansas City Business Journal as a 2018 Champion of Business award winner. The award recognizes area businesses that excel in financial performance, innovation and community involvement. This is the second time MedTrakRx has been honored with this prestigious award, which they will receive along with other recipients during the 12^th annual awards luncheon on May 4 at the Intercontinental Hotel in Kansas City.

Pharmacy Compounding Accreditation Board (PCAB) Recognizes EnvisionPharmacies for Operational and Clinical Excellence in the Creation of Customized Medications

PRESS RELEASE: EnvisionPharmacies, a division of EnvisionRxOptions, announced that its compounding pharmacy received accreditation from the Pharmacy Compounding Accreditation Board (PCAB), a service of Accreditation Commission for Health Care (ACHC). This accreditation demonstrates commitment to the highest industry standards for quality and safety. EnvisionPharmacies also holds accreditation for both Mail and Specialty Pharmacy from URAC, a healthcare management accrediting organization.

PRESS RELEASE: We are excited to share some important news that will make EnvisionRxOptions part of a leading food, health and wellness company with expanded capabilities to better serve our patients and clients. This morning, Rite Aid and Albertsons Companies, one of the nation’s largest grocery retailers, announced they have entered into a merger agreement to create a truly unique enterprise.

Combination Will Create Strong Local Networks in Attractive Geographies
 

Integrated Platform Will Provide Customers Greater Choice, Convenience, and Access, and Accelerate Omni-Channel Strategy to Reach More Customers and Drive Profitable Growth
 

John Standley to Serve as Chief Executive Officer and Bob Miller to Serve as Chairman of Combined Company

Transaction Expected to Generate Run Rate Cost Synergies of $375 Million and Create Incremental Revenue Opportunities of Over $3.6 Billion

Combined Company Expected to Generate Pro Forma 20181 Revenues of $83 Billion and Adjusted Pro Forma EBITDA of $3.7 Billion (Including Run Rate Cost Synergies)

PRESS RELEASE: EnvisionRx, a pharmacy benefit manager (PBM) and division of EnvisionRxOptions, a wholly owned subsidiary of Rite Aid Corporation, today announced it has achieved renewal of the Drug Therapy Management (DTM) accreditation by URAC. This accreditation recognizes healthcare organizations that provide innovative ways to manage and incorporate DTM into their clinical care management programs. EnvisionRx is one of only four organizations to accomplish this accreditation, which Envision has held since 2007.